Reference : Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/153706
Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL
English
Verhoef, G. []
Schroyens, W. []
Bron, D. []
Bonnet, Christophe mailto [Université de Liège - ULiège > > GIGA-R : Hématologie >]
De Wilde, V. []
Van Hoof, A. []
Janssens, A. []
Dierickx, D. []
André, M. []
Van Den Neste, E. []
2013
Belgian Journal of Hematology
Ariez Medical Publishing
4 (2)
51-57
Yes
National
Amsterdam
The Netherlands
[en] diffuse large B-cell lymphoma ; guidelines
http://hdl.handle.net/2268/153706
also: http://hdl.handle.net/2268/163004
The guidelines for adult patients in this article are based on 2011 ESMO and NCCN version 4.2011 guidelines and amended for the particular Belgian context of label prescription and reimbursement. Levels of evidence for the use of treatment recommandations are given in square brackets. Statements without grading were considered justified standard clinical practice by the experts of the BHS-lymphoma working party.

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
BJH- Guidelines for newly diagnosed diffuse... 2013.pdfPublisher postprint794.96 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.